NewDays raises a $8.5M Other round

NewDays delivers personalized cognitive treatment that combines expert-led therapy with AI-powered daily practice for people experiencing mild cognitive impairment (MCI) or early dementia. Our science-backed, non-drug approach is designed to maintain cognitive function, build confidence, and help people live the way they want to live. Founded in 2024 by leaders from Amazon and Google X, NewDays makes clinically-validated cognitive interventions accessible through breakthrough AI technology and expert clinical oversight.